Member Info for BuenaVista

RFK Jr. is Trump and Project 2025's wrecking ball for the biomedical industry.

RFK Jr. May Ban NIH Scientists From Publishing in Top Medical Journals

https://www.medpagetoday.com/washington-watch/washington-watch/115794

"HHS will "probably" prevent NIH scientists from submitting their research to The Lancet, the New England Journal of Medicine, or JAMA because "they're all corrupt" due to pharmaceutical industry money, Secretary Robert F. Kennedy Jr. said Tuesday.

"Pharmaceutical funding holds scientists "hostages because they know what the outcome is and they write the outcome before they write the study," Kennedy said on "The Ultimate Human" podcast with Gary Brecka -- which ironically was frequently interrupted by pharma ads for Evenity, Entyvio, and several other products.

"He noted that some journal editors themselves have pointed out problems with pharmaceutical influence over the yearsopens in a new tab or window, including long-time and former New England Journal of Medicine editor Marcia Angell, MD, who Kennedy claimed criticized journals for becoming "a vessel for pharmaceutical propaganda. Because they control the journals."

"!

How is this a problem for NIH researchers? In Kennedy's mind, the 56,000 NIH grants handed out to researchers around the world -- some $46 billion in total, and most of them are in the U.S. -- "tend to be the people who have been approved by the industry. ... Part of an old boys network that knows what they can say and what they can't say."

"Kennedy also blasted the system by which the journals get paid. The pharmaceutical companies fund a study "that shows the outcome that they want, that statins work or that SSRIs work ... and they order reprints from the journal ... then give them to the pharmaceutical reps," he said. "Hot-looking girls or hot-looking guys go to the doctor's office, take them to lunch and give them the reprint to say this product works."

"Instead of continuing this "corrupt" system, HHS will "create our own journals in-house ... [and] they will become the prominent journals," he said.

"That's a move that some of Kennedy's direct reports have been involved with before. NIH Director Jay Bhattacharya, MD, PhD, and FDA Commissioner Marty Makary, MD, MPH, were both involved in the creation of the Journal of the Academy of Public Healthopens in a new tab or window, which they billed as an alternative to traditional publishing.

"James Lawler, MD, MPH, an infectious diseases expert at the University of Nebraska Medical Center's Global Center for Health Security, made a quip about Kennedy's HHS journal: "If we couldn't get any more Ministry-of-Truth-ish, now we have," he said. "If you wanted to instantiate '1984' into real life, this is it."

"In response to Kennedy's comments, the NEJM said in a statement that it is "one of the most trusted medical journals, with an impeccable record of scientific rigor and independence. We use rigorous peer review and editorial processes [continues]

America, land of the fee, will have nothing to do with the Socialism of a publicly funded healthcare system like the NHS with it's 'death panels'.

As usual a complete load of twaddle totally devoid of context.

In general, non-executive directors of an AIM (Alternative Investment Market) company are not required to declare their spouse's shareholding in the company. However, they may be required to disclose potential conflicts of interest stemming from their spouse's shareholdings or other relationships.

Here's a more detailed explanation:

No specific requirement for spousal shareholding declarations:

While directors are expected to disclose their own shareholdings and interests in the company, there isn't a blanket rule requiring them to disclose their spouse's shareholdings.

Duty to disclose potential conflicts:

A director must disclose any potential or actual conflict of interest, and this may include situations where a spouse's shareholdings could lead to a conflict.

Independence and impartiality:

Non-executive directors are expected to be independent and impartial, and potential conflicts must be disclosed to the board so they can assess the impact on the director's ability to act in the best interests of the company.

Company policies:

Individual company policies may have specific requirements for disclosure, so it's always best to refer to the specific AIM company's governance guidelines.

I told you before HurstBot that AstraZeneca didn't just sign up with Tempus. Their agreement dates back to 2021. But carry on posting Scheiße.

It is stated at the end of the RNS that "Richard Hughes does not hold any ordinary shares in Avacta" so something doesn't add up if he has been buying shares recently.

Also, if his wife still holds shares (and not sold them, at a profit) then that should surely have been declared since she is a connected person.

Good to know someone's on the ball 54retiresoon!

Ah! Thanks. I wonder what happened to his holding then. Sold (at a loss, so he'll want to make it back) or held by Medusa 19, etc?

The list of seven failed companies doesn't look good.

At last a director with some real skin in the game. RH will want to see the share price take off.

So the real reason for the change of date was a desperate attempt to lose all our awkward questions.

The most amusing thing about Professor Eggy is that he doesn't bother to read or watch anything Avacta puts out but rather just takes his talking points and 10p's from his paymaster, him with the bad teeth. This of course makes the Prof look a complete imbecile when he tries to make a point that is immediately and categorically invalidated by what Avacta just put out. Eggy on face.

@McNuff, are you saying the reason given in the RNS for the prelims p postponement is NOT the real reason? Evidence?

...was never working exclusively for Avacta. He works for his own independent consultancy.

Simon is going to be an even more busy independent consultant now working for yet another company. Where does he find the time?

The other thing you need know about Professor Eggy is that he knows nothing about Avacta's science and is just paid by Tom Winnifrith to post meaningless talking points.

Use tiny URL

Avacta need to send Harry the Nutter round to those recalcitrant farmers to get them to sign deals on Avacta's terms.

So no source quoted for such detailed information. Holders seem to be a mixture of investment funds and brokerages.

Thank you Thompi.

@Knotagain - or anyone else, could you please post the link to Tom's Xcretion? (I'm currently unable to log in so can't use TwiX that way.)

I'd like to check what he wrote and what his source is as I suspect the organisations he's listed are holding Avacta shares for investors, not investing themselves. For example, WH Ireland Group is a personal wealth management firm: https://www.whirelandplc.com/ and Fidelity, MS and GS are brokers as well as fund managers and the numbers of shares added by MS and GS are insignificant and not noteworthy.